<!DOCTYPE html>
<html lang="en">
<head>
<meta charset="utf-8">
<meta name="viewport" content="width=device-width, initial-scale=1">
<title>Adverse Reactions &amp; Anaphylaxis — Paramedic Aid Memoir</title>
<link rel="stylesheet" href="../../styles/style.css">
<script src="../../scripts/app.js" defer></script>
</head>
<body>
<header class="site-header">
  <span class="site-title">Paramedic Aid Memoir</span>
  <a href="../../index.html">Home</a>
<a href="index.html">&larr; Immunizations</a>
</header>
<main class="content">
<h1>Adverse Reactions &amp; Anaphylaxis</h1>
<p class="scope-block">Every immunization session must have anaphylaxis supplies immediately accessible. Know the signs and act without delay.</p>

<h2>Types of Adverse Events Following Immunization (AEFI)</h2>
<h3>Common / Expected Reactions</h3>
<ul>
  <li>Local: pain, redness, swelling at injection site — onset within hours, resolves in 1–3 days.</li>
  <li>Systemic: low-grade fever, malaise, myalgia, headache — onset 6–24 hours, resolves in 1–2 days.</li>
  <li>Management: cold compress to site, acetaminophen or ibuprofen for comfort. No treatment usually required.</li>
</ul>

<h3>Vasovagal Syncope (Fainting)</h3>
<ul>
  <li>Signs: pallor, diaphoresis, lightheadedness, nausea, brief loss of consciousness.</li>
  <li>Onset: usually within 15 minutes of injection (hence the observation period).</li>
  <li>Management: lay the patient supine with legs elevated, protect from falling injury, monitor until fully recovered. This is <strong>not</strong> anaphylaxis.</li>
</ul>

<h3>Anaphylaxis</h3>
<ul>
  <li>A severe, life-threatening systemic allergic reaction. Onset usually within minutes (up to 30 minutes) of vaccination.</li>
  <li><strong>Key signs:</strong> urticaria (hives) or angioedema, respiratory distress (stridor, wheeze, dyspnea), hypotension, tachycardia, GI symptoms (nausea, vomiting, cramping), sense of impending doom.</li>
  <li>Distinguishing from vasovagal: anaphylaxis involves <strong>urticaria/angioedema and/or respiratory compromise and/or hypotension</strong>; vasovagal typically involves <strong>bradycardia</strong> (not tachycardia) and <strong>no rash or respiratory distress</strong>.</li>
</ul>

<h2>Anaphylaxis Management Protocol</h2>
<ol>
  <li><strong>Recognize it early</strong> — do not delay treatment waiting for "classic" presentation. If in doubt, treat as anaphylaxis.</li>
  <li><strong>Call for help:</strong> Alert the primary immunizer and activate the emergency response as per unit SOP.</li>
  <li><strong>Epinephrine IM — FIRST-LINE:</strong>
    <ul>
      <li>Adult dose: 0.5 mg (0.5 mL of 1:1000 concentration) IM into the mid-anterolateral thigh.</li>
      <li>Auto-injector (EpiPen): 0.3 mg for adults — use through clothing if necessary.</li>
      <li>Repeat every 5–15 minutes if symptoms persist or recur. There is no maximum number of doses in a life-threatening situation.</li>
    </ul>
  </li>
  <li><strong>Position:</strong> Lay supine with legs elevated unless respiratory distress requires a sitting position. Do not stand the patient up.</li>
  <li><strong>Oxygen:</strong> High-flow oxygen via non-rebreather mask if available.</li>
  <li><strong>IV access:</strong> Establish if trained and equipped; administer normal saline bolus (1–2 L) for hypotension.</li>
  <li><strong>Monitor:</strong> Continuous vital signs — HR, BP, SpO2, respiratory status.</li>
  <li><strong>Secondary medications</strong> (adjuncts, not substitutes for epinephrine):
    <ul>
      <li>Diphenhydramine (Benadryl) 50 mg IM/IV — for urticaria/itching.</li>
      <li>Salbutamol (Ventolin) nebulized — for bronchospasm not responding to epinephrine.</li>
      <li>Consider corticosteroids (methylprednisolone) — may help prevent biphasic reaction but does not treat acute anaphylaxis.</li>
    </ul>
  </li>
  <li><strong>Observe:</strong> Minimum 4–6 hours post-reaction due to risk of biphasic anaphylaxis (recurrence of symptoms hours later).</li>
  <li><strong>Arrange evacuation</strong> if on ship and the patient is not improving or if the reaction was severe.</li>
</ol>

<h2>Anaphylaxis Kit Contents</h2>
<p>The following must be immediately available at every immunization session:</p>
<ul>
  <li>Epinephrine 1:1000 ampoules (at least 3) <strong>and/or</strong> EpiPen auto-injectors (at least 2).</li>
  <li>Syringes (1 mL and 3 mL) and needles (25G x 25mm for IM).</li>
  <li>Diphenhydramine 50 mg injectable.</li>
  <li>Salbutamol MDI with spacer or nebulizer solution + nebulizer.</li>
  <li>Oxygen source and non-rebreather mask.</li>
  <li>Oral/nasal airway adjuncts.</li>
  <li>Blood pressure cuff and stethoscope (or automated BP monitor).</li>
  <li>Pulse oximeter.</li>
</ul>

<h2>AEFI Reporting</h2>
<ul>
  <li>All serious adverse events (anaphylaxis, hospitalization, persistent disability, or any event of concern) must be reported.</li>
  <li>Complete the CF AEFI reporting form and submit to CF H Svcs Gp within 24 hours for serious events.</li>
  <li>Enter the event in CFHIS with full details: time of onset, symptoms, treatment given, and outcome.</li>
  <li>Notify the primary immunizer immediately for any reaction beyond expected local/systemic effects.</li>
</ul>
</main>
<footer class="site-footer">Last updated: 2026-02-12 &bull; Offline-first &bull; v0 framework</footer>
</body>
</html>
